Patent ID: 11859006
Assignee: SAITAMA MEDICAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C

Claim 1:
2. The method according to claim 1, wherein the antibody or the antigen-binding fragment thereof comprises a heavy chain variable region comprising a CDRH1, a CDRH2, and a CDRH3, which comprise the amino acid sequences of:
SEQ ID NO: 5, SEQ ID NO: 6, and SEQ ID NO: 7, respectively,
SEQ ID NO: 11, SEQ ID NO: 12, and SEQ ID NO: 13, respectively,
SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 20, respectively, or
SEQ ID NO: 24, SEQ ID NO: 25, and SEQ ID NO: 26, respectively; and
a light chain variable region comprising a CDRL1, a CDRL2, and a CDRL3, which comprise the amino acid sequences of:
SEQ ID NO: 8, SEQ ID NO: 9, and SEQ ID NO: 10, respectively,
SEQ ID NO: 8, SEQ ID NO: 17, and SEQ ID NO: 10, respectively,
SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively,
SEQ ID NO: 21, SEQ ID NO: 22, and SEQ ID NO: 23, respectively, or
SEQ ID NO: 27, SEQ ID NO: 28, and SEQ ID NO: 29, respectively.